• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于糖原的纳米载药粒子的构建及其用于缓解高脂饮食诱导的非酒精性脂肪肝

Construction of Glycogen-Based Nanoparticles Loaded with Resveratrol for the Alleviation of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.

机构信息

National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, P. R. China.

Jiangxi Health Vocational College, Nanchang 330052, China.

出版信息

Biomacromolecules. 2022 Jan 10;23(1):409-423. doi: 10.1021/acs.biomac.1c01360. Epub 2021 Dec 29.

DOI:10.1021/acs.biomac.1c01360
PMID:34964604
Abstract

The purpose of this study was to construct a glycogen (Gly)-based nanoparticle (NP) with liver-targeted and redox response to effectively deliver resveratrol (Res) for improving nonalcoholic fatty liver disease (NAFLD). Herein, Gly was modified using α-lipoic acid (α-LA) and lactobionic acid (Lac) to obtain an amphiphilic polymer (Gly-LA-Lac), which was self-assembled in water and then encapsulated in Res to form Res NPs with excellent stability. As expected, the Res NPs exhibited liver-targeted and redox response release behavior. cell studies demonstrated that the nanocarrier treatment enhanced the cellular uptake of Res and reduced oxidative stress and inflammatory factor levels. Meanwhile, the tests proved that the nanocarriers effectively reduced hepatic lipid accumulation and oxidative stress levels regulating the TLR4/NF-κB signal pathway to improve liver damage in NAFLD mice. In conclusion, this study provides a promising strategy through the construction of Gly-based nanocarriers for the encapsulation of Res to effectively alleviate the process of NAFLD.

摘要

本研究旨在构建一种基于糖原(Gly)的纳米粒子(NP),具有肝靶向和氧化还原响应性,以有效递送白藜芦醇(Res),从而改善非酒精性脂肪性肝病(NAFLD)。在此,使用α-硫辛酸(α-LA)和乳酰乳酸(Lac)对 Gly 进行修饰,得到一种两亲性聚合物(Gly-LA-Lac),它在水中自组装,然后将 Res 包裹在其中,形成具有优异稳定性的 Res NPs。正如预期的那样,Res NPs 表现出肝靶向和氧化还原响应性释放行为。细胞研究表明,该纳米载体处理增强了 Res 的细胞摄取,并降低了氧化应激和炎症因子水平。同时,试验证明纳米载体有效减少了肝脂质积累和氧化应激水平,通过调节 TLR4/NF-κB 信号通路,改善了 NAFLD 小鼠的肝损伤。总之,本研究通过构建基于 Gly 的纳米载体来封装 Res,为有效缓解 NAFLD 提供了一种有前途的策略。

相似文献

1
Construction of Glycogen-Based Nanoparticles Loaded with Resveratrol for the Alleviation of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.基于糖原的纳米载药粒子的构建及其用于缓解高脂饮食诱导的非酒精性脂肪肝
Biomacromolecules. 2022 Jan 10;23(1):409-423. doi: 10.1021/acs.biomac.1c01360. Epub 2021 Dec 29.
2
The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease.载姜黄素的肝靶向纳米粒缓解高脂饮食诱导的非酒精性脂肪肝
J Control Release. 2019 Aug 10;307:139-149. doi: 10.1016/j.jconrel.2019.06.023. Epub 2019 Jun 22.
3
Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol.用白藜芦醇治疗大鼠高尿酸血症相关非酒精性脂肪肝。
Biomed Pharmacother. 2019 Feb;110:844-849. doi: 10.1016/j.biopha.2018.12.039. Epub 2018 Dec 14.
4
Resveratrol Attenuates High-Fat Diet-Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression.白藜芦醇通过上调 Bmi-1 表达减轻高脂饮食诱导的肝脂毒性。
J Pharmacol Exp Ther. 2022 May;381(2):96-105. doi: 10.1124/jpet.121.001018. Epub 2022 Feb 27.
5
Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh for effective treatment of ulcerative colitis.基于糖原的 pH 值和氧化还原敏感纳米颗粒与人参皂苷 Rh 联合用于溃疡性结肠炎的有效治疗。
Biomaterials. 2022 Jan;280:121077. doi: 10.1016/j.biomaterials.2021.121077. Epub 2021 Aug 20.
6
Hepatic-Targeted Nano-enzyme with Resveratrol Loading for Precise Relief of Nonalcoholic Steatohepatitis.载白藜芦醇的肝靶向纳米酶用于精准缓解非酒精性脂肪性肝炎
ChemMedChem. 2023 Mar 1;18(5):e202200468. doi: 10.1002/cmdc.202200468. Epub 2023 Feb 9.
7
Engineered Fenofibrate as Oxidation-Sensitive Nanoparticles with ROS Scavenging and PPARα-Activating Bioactivity to Ameliorate Nonalcoholic Fatty Liver Disease.工程化非诺贝特作为具有活性氧清除和过氧化物酶体增殖物激活受体α激活生物活性的氧化敏感纳米颗粒,用于改善非酒精性脂肪性肝病。
Mol Pharm. 2023 Jan 2;20(1):159-171. doi: 10.1021/acs.molpharmaceut.2c00549. Epub 2022 Nov 7.
8
Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.白杨素通过改善氧化应激、炎症反应和脂代谢改善高脂饮食诱导的非酒精性脂肪性肝病(NAFLD)。
Biomed Pharmacother. 2018 Jan;97:1397-1408. doi: 10.1016/j.biopha.2017.10.035. Epub 2017 Dec 14.
9
Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.白藜芦醇通过激活 PPARα 通路改善脂代谢和氧化还原平衡,从而防治非酒精性脂肪性肝病。
Appl Physiol Nutr Metab. 2020 Mar;45(3):227-239. doi: 10.1139/apnm-2019-0057. Epub 2019 Jun 7.
10
The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.白藜芦醇通过改善氧化应激、炎症和脂质相关基因转录表达对高脂饮食诱导的肥胖小鼠肝脂肪变性的治疗作用。
Med Mol Morphol. 2019 Dec;52(4):187-197. doi: 10.1007/s00795-019-00216-7. Epub 2019 Jan 23.

引用本文的文献

1
Pharmacological and therapeutic effects of natural products on liver regeneration-a comprehensive research.天然产物对肝脏再生的药理及治疗作用——一项综合研究
Chin Med. 2025 May 6;20(1):57. doi: 10.1186/s13020-025-01108-y.
2
Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection.非酒精性脂肪性肝病中的治疗性纳米材料:在合并乙型肝炎病毒感染患者中的当前进展及潜在应用
Int J Nanomedicine. 2025 Mar 25;20:3803-3823. doi: 10.2147/IJN.S510271. eCollection 2025.
3
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.
白藜芦醇治疗非酒精性脂肪性肝病的综合证据构建:临床前和临床荟萃分析
Front Pharmacol. 2023 Sep 12;14:1230783. doi: 10.3389/fphar.2023.1230783. eCollection 2023.
4
Harnessing dual-energy CT for glycogen quantification: a phantom analysis.利用双能CT进行糖原定量分析:体模分析
Quant Imaging Med Surg. 2023 Aug 1;13(8):4933-4942. doi: 10.21037/qims-22-1234. Epub 2023 May 24.
5
Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats regulation of PI3K/AKT/FoxO1 pathway.锌氧化物纳米载芦丁可改善糖尿病大鼠非酒精性脂肪肝疾病并伴有胰岛素抵抗 通过调控 PI3K/AKT/FoxO1 信号通路。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221137435. doi: 10.1177/03946320221137435.